TYRA - CIK 0001863127
Tyra Biosciences, Inc. (TYRA) reported net income of -$119.95M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Net Income | Change |
|---|---|---|
| FY 2025 | -$119.95M | -38.7% |
| FY 2024 | -$86.48M | -25.1% |
| FY 2023 | -$69.13M | -25.0% |
| FY 2022 | -$55.33M | -110.4% |
| FY 2021 | -$26.29M | -181.6% |
| FY 2020 | -$9.34M | - |
Tyra Biosciences, Inc. (TYRA) reported net income of -$119.95M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2020 and fiscal 2025, Tyra Biosciences, Inc.'s net income declined from -$9.34M to -$119.95M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.